Navigation Links
Biotechnology Salutes America's Veterans; Innovations Continue to Offer Improved Treatment and Care of Combat Troops
Date:11/11/2009

On-the-battlefield surgical sealants, advancements in blood substitutes and stem cell treatments for bone and tissue re-growth

WASHINGTON, Nov. 11 /PRNewswire-USNewswire/ -- The WhatCanBiotechDoForYou campaign saluted American veterans across the country today for their service in defense of the United States. The biotechnology industry has consistently supported these brave men and women, both veterans and current soldiers, through innovative breakthroughs in medical treatment on and off the battlefield. Today, these innovations include on-the-battlefield surgical sealants, advancements in blood substitutes and stem cell treatments for bone and tissue re-growth after traumatic injuries.

A WhatCanBiotechDoForYou campaign spokesperson said today, "Today every American honors the commitment and sacrifices made by our veterans in defense of the United States. We are proud to be at the forefront of lifesaving treatments for our heroes wounded in action and will continue to honor their dedication to us with our dedication to advancing the biotechnologies needed to care for them."

The WhatCanBiotechDoForYou campaign outlined many of these advancements today in a post on its website, www.whatcanbiotechdoforyou.com. They include:

  • BioFoam, a surgical sealant developed by Georgia-based CryoLife, seals large, life-threatening wounds almost immediately on the battlefield. The substance is contained in a two-chamber applicator and upon contact, expands five-fold into a foam which sets within 15 to 20 seconds and reaches full bonding strength within two minutes. The research is currently in animal trials and testing.
  • The military has worked for an alternative to human blood for a decade to no avail. The DoD is in discussions with HemoBioTech of Dallas, Texas who may have solved the riddle. Previous attempts at developing blood substitutes resulted in problems with toxicity; however, the FDA has cited this technology (last April) at a blood substitute meeting as a promising new-generation strategy.
  • Another separate technology holds hope to dramatically help soldiers re-grow bone and tissue after traumatic injuries. Georgia Tech researchers have discovered that stem cells, when encapsulated in microbeads, can be injected and stay at injury sites for up to two months, eventually transforming into the cells which grow bone and tissue. The technology is currently in pre-clinical stages.

To learn more about advancements in the biotechnology industry related to care for our soldiers and the biotechnology industry in general, visit www.WhatCanBiotechDoForYou.com or www.IAmBiotech.org.

About WhatCanBiotechDoForYou.com

WhatCanBiotechDoForYou.com is part of a project sponsored by the Biotechnology Industry Organization (BIO), designed to foster a conversation with the general public about biotechnology and further educate people about the contributions of this innovative sector. For more in-depth information on biotech and the people behind the science, please visit our sister site - www.IAmBiotech.org.

SOURCE The WhatCanBiotechDoForYou campaign


'/>"/>
SOURCE The WhatCanBiotechDoForYou campaign
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
6. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
10. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
11. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017 The Mobile X-Ray product segment is ... CAGR during the forecast period Mobile X-Ray segment ... digital mobile X-Ray devices market, which is estimated to be ... at a CAGR of 7% over the forecast period. Mobile ... more than US$ 100 Mn in 2017 over 2016. The ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology:
(Date:4/28/2017)... Washington, DC (PRWEB) , ... April 28, 2017 ... ... Unplanned Pregnancy (The National Campaign) announces its support for the Access to ... by Sen. Jeanne Shaheen (D-NH) and Rep. Jackie Speier (D-CA), will help to ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce its ... has been in place since the RBMA was founded in 1968 with all board ... Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for Clinical ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... ... cardiac or hERG liability could substantially improve drug safety and minimize the cost ... provided for validating ion channel inhibition using cell lines and for cardiac toxicity ...
(Date:4/28/2017)... UTAH (PRWEB) , ... April 28, 2017 , ... ... Account Manager for the North East region. Côté has 20+ years of experience ... Prior to Phytomer, Côté worked with an array of high-end cosmetic brands, retail ...
Breaking Medicine News(10 mins):